Yue Tao

Dr. Yue Tao


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 December 2019 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
NSNan Shen
Nan Shen
JDJun Du
Jun Du
HZHui Zhou
Hui Zhou
NCNan Chen
Nan Chen
YPYi Pan
Yi Pan
XMXi Mo
Xi Mo
Lung adenocarcinoma (LUAD) is one of the most common cancers and lethal diseases in the world. Recognition of the undetermined lung nodules at an early stage is useful for a favorable prognosis. However, there is no good method to identify the undetermined lung nodules and predict their clinical outcome. DNA methylation alteration is frequently observed in LUAD and may play important roles in carcinogenesis, diagnosis, and prediction. This study took advantage of publicly available methylation profiling resources and a machine learning method to investigate methylation differences between LUAD and adjacent non-malignant tissue. The prediction panel was first constructed using 338 tissue samples from LUAD patients including 149 non-malignant ones. This model was then validated with data from The Cancer Genome Atlas database and clinic samples. As a result, the methylation status of four CpG loci in homeobox A9 (HOXA9), keratin-associated protein 8-1 (KRTAP8-1), cyclin D1 (CCND1), and tubby-like protein 2 (TULP2) were highlighted as informative markers. A random forest classification model with an accuracy of 94.57% and kappa of 88.96% was obtained. To evaluate this panel for LUAD, the methylation levels of four CpG loci in HOXA9, KRTAP8-1, CCND1, and TULP2 of tumor samples and matched adjacent lung samples from 25 patients with LUAD were tested. In these LUAD patients, the methylation of HOXA9 was significantly upregulated, whereas the methylation of KRTAP8-1, CCND1, and TULP2 were downregulated obviously in tumor samples compared with adjacent tissues. Our study demonstrates that the methylation of HOXA9, KRTAP8-1, CCND1, and TULP2 has great potential for the early recognition of LUAD in the undetermined lung nodules. The findings also exhibit that the application of improved mathematic algorithms can yield accurate and particularly robust and widely applicable marker panels. This approach could greatly facilitate the discovery process of biomarkers in various fields.

19 October 2023 in Pediatric Research
Verified
Journal Article
Open access
PDF file
JWJing Wu
Jing Wu
WSWenting Song
Wenting Song
HYHui Yan
Hui Yan
CLChengjuan Luo
Chengjuan Luo
WHWenting Hu
Wenting Hu
YTYue Tao
Yue Tao
Background: Studies on mNGS application in pediatric oncology patients, who are at high risk of infection, are quite limited. Methods: From March 2020 to June 2022, a total of 224 blood samples from 195 pediatric oncology patients who were suspected as bloodstream infections were enrolled in this study. Their clinical and laboratory data were retrospectively reviewed, and the diagnostic performance of mNGS was assessed. Results: Compared to the reference tests, mNGS showed significantly higher sensitivity (89.8% vs 32.5%, P < 0.001) and clinical agreement (76.3% vs 51.3%, P < 0.001) in detecting potential pathogens and distinguishing BSI from non-BSI. Especially, mNGS had an outstanding performance for virus detection, contributing to 100% clinical diagnosed virus. Samples from patients with neutropenia showed higher incidence of bacterial infections (P = 0.035). The most identified bacteria were Escherichia coli, and the overall infections by gram-negative bacteria were significantly more prevalent than those by gram-positive ones (90% vs 10%, P < 0.001). Overall, mNGS had an impact on the antimicrobial regimens’ usage in 54.3% of the samples in this study. Conclusions: mNGS has the advantage of rapid and effective pathogen diagnosis in pediatric oncology patients with suspected BSI, especially for virus. Impact: Compared with reference tests, mNGS showed significantly higher sensitivity and clinical agreement in detecting potential pathogens and distinguishing bloodstream infections (BSI) from non-BSI. mNGS is particularly prominent in clinical diagnosed virus detection. The incidence of bacterial infection was higher in patients with neutropenia, and the overall infection rate of Gram-negative bacteria was significantly higher than that of Gram-positive bacteria. mNGS affects the antimicrobial regimens’ usage in more than half of patients.

1 September 2019 in Annals of Translational Medicine
Verified
Journal Article
Closed access
PDF file
BDBailu Du
Bailu Du
CHChunzhen Hua
Chunzhen Hua
YXYijun Xia
Yijun Xia
JLJin Li
Jin Li
YXYongping Xie
Yongping Xie
XMXi Mo
Xi Mo
Background: Meningitis and encephalitis are life-threatening syndromes with high morbidity and mortality in children. Due to limitations of traditional laboratory approaches in etiological diagnosis, the rate of misdiagnoses is unacceptably high. Methods: We retrospectively compared the potential clinical impact of the FilmArray meningitis/encephalitis (ME) panel vs. conventional cerebrospinal fluid (CSF) culture in children with central nervous system (CNS) infections. Sixty-eight pediatric patients (<18 years of age) with an initial diagnosis of meningitis or encephalitis were enrolled at 2 children’s hospital from January to October 2017. Results: Fifteen specimens were found to be positive after CSF culture, with a positive rate of 22.1% (15/68). For the FilmArray ME panel, 26 bacteria and fungi from 25 samples were detected, and the positive rate was 36.8% (25/68). The FilmArray ME panel identified 14 pathogens in previously pathogen-negative patients. Conclusions: This study demonstrated the capability of the FilmArray ME panel in the diagnosis of bacterial and fungal meningitis and therefore its potential use in facilitating enhanced patient care.

20 June 2025 in Advanced Photonics
Verified
Journal Article
Open access
PDF file
HCHaoran Chen
Haoran Chen
RZRuike Zhao
Ruike Zhao
XBXinyuan Bi
Xinyuan Bi
NSNan Shen
Nan Shen
XMXi Mo
Xi Mo
Jian YeJian Ye
Jian Ye
Bacterial infections have constituted a substantial global public health threat, particularly in healthcare settings.1 Bacterial infection–related diseases have experienced a remarkable increase after the COVID-19 pandemic which has exacerbated the general decline in immunity.2 An annual mortality exceeding 10 million deaths has been reported to be associated with bacterial infections.3 Rapid and precise early diagnosis of bacterial infections becomes essential for rational interventions and treatments, considering the rapid reproduction rate in bloodstream infections.4 Mass spectrometry has been a widely adopted and commercialized clinical modality for bacterial diagnosis based on the advancing property of peptide mass fingerprinting. Quantitative polymerase chain reaction (qPCR) and next-generation sequencing (NGS) provide alternative identification approaches, which significantly reduce culture time by targeting specific gene sequences. Despite the remarkable progress, these techniques highly depend on expensive investment, rigorous experimental conditions, and well-qualified operators.5,6 In addition, due to the imbalanced deployment of diagnostic services, patients in less developed areas are less likely to benefit from advanced early diagnosis devices.7,8

1 June 2020 in Comparative Immunology, Microbiology and Infectious Diseases
Verified
Journal Article
Closed access
BDBailu Du
Bailu Du
NSNan Shen
Nan Shen
JHJinfeng Hu
Jinfeng Hu
YTYue Tao
Yue Tao
XMXi Mo
Xi Mo
QCQing Cao
Qing Cao

12 August 2022 in Communications Biology
Verified
Journal Article
Open access
PDF file
NJNan Jia
Nan Jia
GLGuo Li
Guo Li
XWXing Wang
Xing Wang
QCQing Cao
Qing Cao
WCWanbiao Chen
Wanbiao Chen
JHJinfeng Hu
Jinfeng Hu
Staphylococcal aureus (S. aureus) infection can lead to a wide range of diseases such as sepsis and pneumonia. Staphylococcal superantigen-like (SSL) proteins, expressed by all known S. aureus strains, are shown to be involved in immune evasion during S. aureus infection. Here, we show that SSL10, an SSL family protein, exhibits potent cytotoxicity against human cells (HEK293T and HUVEC) by inducing necroptosis upon binding to its receptor TNFR1 on the cell membrane. After binding, two distinct signaling pathways are activated downstream of TNFR1 in a RIPK3-dependent manner, i.e., the RIPK1-RIPK3-MLKL and RIPK3-CaMKII-mitochondrial permeability transition pore (mPTP) pathways. Knockout of ssl10 in S. aureus significantly reduces cytotoxicity of the culture supernatants of S. aureus, indicating that SSL10 is involved in extracellular cytotoxicity during infection. We determined the crystal structure of SSL10 at 1.9 Å resolution and identified a positively charged surface of SSL10 responsible for TNFR1 binding and cytotoxic activity. This study thus provides the description of cytotoxicity through induction of necroptosis by the SSL10 protein, and a potential target for clinical treatment of S. aureus-associated diseases.